Sign in

CIK 0001671584

  • Non-accelerated filer
  • Smaller reporting company

Aptevo Therapeutics Inc.

Sign in to watch
Ticker
APVO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
811567056
Phone
+1 206-838-0500
Business address
2401 4TH AVE., SUITE 1050, SEATTLE, WA, 98121
  1. 4 Open-market buy Board of Directors bought 14,691 shares at $0.85 ($12,454)
  2. 4 Open-market buy Director bought 18,919 shares at $0.85 ($16,058)
  3. 4 Open-market buy Board of Directors bought 16,667 shares at $0.90 ($15,000)
  4. 4 Open-market buy President and CEO bought 50,000 shares at $0.88 ($44,000)
  5. 4 Open-market buy Board of Directors bought 10,000 shares at $0.85 ($8,481)
  6. 4 Open-market buy Board of Directors bought 50,000 shares at $0.78 ($39,000)
  7. 4 Open-market buy Senior VP, Operations bought 20,000 shares at $0.73 ($14,600)
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Open-market buy Board of Directors bought 10,000 shares at $0.80 ($7,970)
  15. 4 Open-market buy President and CEO bought 30,000 shares at $0.81 ($24,300)
  16. 4 Open-market buy President and CEO bought 10,000 shares at $0.78 ($7,800)
  17. 4 Derivatives Options or other derivatives
  18. 4 Shares withheld for taxes Chief Medical Officer and SVP gave up 4,823 shares (to pay taxes)
  19. 4 Shares withheld for taxes SVP, GC and Corporate Affairs gave up 2,012 shares (to pay taxes)
  20. 4 Derivatives Options or other derivatives

Page 9 of 14 · 265 filings